EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Jasmone Is a Ligand-Selective Allosteric Antagonist of Aryl Hydrocarbon Receptor (AhR)

Radim Vrzal iD, Adéla Marcalíková, Kristýna Krasulová, Lenka Zemánková, Zdeněk Dvořák iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242115655 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Radim Vrzal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic. Hauptthemen laut MEDLINE: Polychlorinated Dibenzodioxins, Receptors, Aryl Hydrocarbon. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Czech Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herbal extracts represent a wide spectrum of biologically active ingredients with potential medical applications. By screening minor constituents of jasmine essential oil towards aryl hydrocarbon receptor (AhR) activity using a gene reporter assay (GRA), we found the antagonist effects of jasmone (3-methyl-2-[(2Z)-pent-2-en-1-yl]cyclopent-2-en-1-one). It inhibited 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-, benzo[a]pyrene (BaP)-, and 6-formylindolo[3,2-b]carbazole (FICZ)-triggered AhR-dependent luciferase activity in a concentration-dependent manner. However, the inhibition differed markedly between TCDD, BaP, and FICZ, with the latter being significantly less inhibited. The dose-response analysis confirmed an allosteric type of AhR antagonism. Furthermore, jasmone efficiently inhibited AhR activation by AhR agonists and microbial catabolites of tryptophan (MICTs). TCDD- and FICZ-inducible CYP1A1 expression in primary human hepatocytes was inhibited by jasmone, whereas in the human HepG2 and LS180 cells, jasmone antagonized only TCDD-activated AhR. Jasmone only partially displaced radiolabeled TCDD from its binding to mouse Ahr, suggesting it is not a typical orthosteric ligand of AhR. TCDD-elicited AhR nuclear translocation was not affected by jasmone, whereas downstream signaling events, including the formation of the AhR:ARNT complex and enrichment of the CYP1A1 promoter, were inhibited by jasmone. In conclusion, we show that jasmone is a potent allosteric antagonist of AhR. Such discovery may help to find and/or clarify the use of jasmone in pharmaco- and phytotherapy for conditions where AhR plays a key role.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polychlorinated DibenzodioxinsReceptors, Aryl HydrocarbonAnimalsHumansMiceCytochrome P-450 CYP1A1LigandsCyclopentanesOxylipins

Stichwörter der Autor:innen

AhRCYP1A1ChIPHepG2LS180jasmone

Substanzen

Cytochrome P-450 CYP1A1LigandsPolychlorinated DibenzodioxinsReceptors, Aryl HydrocarbonjasmoneCyclopentanesOxylipins

Autor:innen und Institutionen

  • Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic.

ORCID-Profile: Radim Vrzal, Zdeněk Dvořák

Förderung

  • Czech Science Foundation

Zitieren

APA

Vrzal, R., Marcalíková, A., Krasulová, K., Zemánková, L., & Dvořák, Z. (2023). Jasmone Is a Ligand-Selective Allosteric Antagonist of Aryl Hydrocarbon Receptor (AhR). International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115655

Vancouver

Vrzal R, Marcalíková A, Krasulová K, Zemánková L, Dvořák Z. Jasmone Is a Ligand-Selective Allosteric Antagonist of Aryl Hydrocarbon Receptor (AhR). International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115655

BibTeX
@article{Vrzal2023,
  author = {Vrzal, Radim and Marcalíková, Adéla and Krasulová, Kristýna and Zemánková, Lenka and Dvořák, Zdeněk},
  title = {Jasmone Is a Ligand-Selective Allosteric Antagonist of Aryl Hydrocarbon Receptor (AhR)},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242115655}
}
Kostenlos starten →